Double shrinkage transfer causal learning: An application to alzheimer's disease

Related

• medRxiv·7 Oct 2026

  Model forecasts Alzheimer's progression before diagnosis

  

• Nature Neuroscience·9 Oct 2026

  Genetic data highlight potential drug targets for Alzheimer's

  

• Journal of Alzheimer's Disease Reports·4 Oct 2026

  Statins cut Alzheimer's risk but raise other dementia risks

  

• Alzheimer's & Dementia·6 Oct 2026

  Genetic risk scores linked to faster progression to Alzheimer’s